Pricing Log in Create free account
Friday 6 November 2026 Export XENE’s income statement to Excel — free account

Xenon Pharmaceuticals Inc.

XENE Healthcare Biotechnology

Xenon Pharmaceuticals Inc.’s revenue for fiscal 2025 (year ended December 2025) was $7.5 million, down 20.5% from fiscal 2022.

Revenue
+100.7%
EPS
−3.74%
Free cash flow
−48.6%

Quarter to June 2026, against a year earlier

39.00 1.32 +3.50%
Market cap
$3.7B
P/E
0.0×
Fwd P/E
−8.1×
Dividend yield
—
F-score
n/a
Altman Z
37.76
Beneish M
n/a
Dividend safety
n/a
Overview
Financials
Income Statement Balance Sheet Cash Flow Metrics & Ratios

Xenon Pharmaceuticals Inc. (XENE) P/S ratio

Alert me on P/S ratio

As of 5 November 2026, Xenon Pharmaceuticals Inc. (XENE) trades at a P/S ratio of 223×. Over the past ten years it has ranged from 1.7× (February 2015) to 890× (June 2019); the current reading is higher than 73% of that period. That is above the Biotechnology industry median of 9.2× and above the Healthcare sector median of 3.5×.

P/S ratio, daily

Embed this chart

Annual newest first

Period P/S ratio Change
FY2025 210× 22.48%
FY2022 171× 131.69%
FY2021 73.9× 347.58%
FY2020 16.5× (65.47%)
FY2019 47.8× (71.28%)
FY2017 167× 146.91%
FY2016 67.5× 815.06%
FY2015 7.4× —

Quarterly newest first

Period P/S ratio Change
Mar 2025 156× (13.12%)
Sep 2022 179× 122.14%
Jun 2022 80.8× 10.04%
Mar 2022 73.4× (0.71%)
22 more quarters

Against its own ten years

Low 1.7× High 890×
Ten-year median 99.8×
Current reading's percentile 70

P/S ratio against peers

Company P/S ratio
VKTX Viking Therapeutics, Inc. compare n/m
PBLS Parabilis Medicines, Inc. compare n/m
IRON Disc Medicine, Inc. compare n/m
ACAD ACADIA Pharmaceuticals Inc. compare 3.1×
IOVA Iovance Biotherapeutics, Inc. compare 9.3×
TNGX Tango Therapeutics, Inc. compare 51.0×
ABCL AbCellera Biologics Inc. compare 51.9×
XENE Xenon Pharmaceuticals Inc. 223×
RLAY Relay Therapeutics, Inc. compare 313×
Biotechnology industry median 9.2×
Healthcare sector median 3.5×
Market median 1.9×

What P/S ratio is

Price to Sales Ratio shows how much investors pay for each dollar of a company’s annual sales, whether or not it is profitable.

(Stock Price × Shares (Basic, Weighted) (latest quarter)) ÷ Revenue (TTM)

The full definition of P/S ratio →

More on XENE